Organigram Reports Second Quarter Fiscal 2023 Results
(marketscreener.com)
Continues trend of improving Adjusted Gross Margin and fifth consecutive quarter of positive Adjusted EBITDA
FINANCIAL HIGHLIGHTS
Net revenue of $39.5 million, up 24% from $31.8 million in the same prior-year period.
Adjusted Gro…
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the second quarter ended February 28, 2023 (“Q2 …